Xencor XNCR
NASDAQ XNCR
$26.61 -0.01 (-0.04%)
As of: Sep 4, 2026 · 3:59 PM EDT

Xencor (XNCR) Invested Capital (2022 - 2026)

Xencor (XNCR) posted quarterly Invested Capital of $26.4 million for Q1 2026, down 49.74% year-over-year from $52.5 million in Q1 2025, and down 38.96% quarter-over-quarter from $43.3 million in Q4 2025.

Analysis

Xencor (XNCR) Invested Capital (2022 - 2026) Analysis & Trends

Xencor (XNCR) has reported Invested Capital for 4 consecutive years, with $26.4 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Invested Capital fell 49.74% year-over-year to $26.4 million; the TTM figure through Mar 2026 stood at $165.3 million (down 10.33% YoY), while the FY2025 annual figure was $43.3 million, down 10.69% from the prior year.
  • Invested Capital declined to $26.4 million in Q1 2026 per XNCR's latest filing, from $43.3 million in the prior quarter.
  • Across five years, Invested Capital topped out at $52.5 million in Q1 2025 and bottomed at $26.4 million in Q1 2026.
  • Historically, Invested Capital has averaged $41.2 million across 4 years, with a median of $43.9 million in 2024.
  • Annual changes were most pronounced in 2024 — Invested Capital jumped 74.83% — and 2026, when it tumbled 49.74%.
  • Xencor's Invested Capital stood at $27.7 million in 2023, then surged by 74.83% to $48.4 million in 2024, then decreased by 10.69% to $43.3 million in 2025, then sank by 38.96% to $26.4 million in 2026.
  • Business Quant data shows XNCR's Invested Capital at $26.4 million in Q1 2026, $43.3 million in Q4 2025, and $45.4 million in Q3 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Invested Cap. (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn -
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 33.70 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 7.35 Bn
5 Revolution Medicines 44.33 Bn 44.33 Bn - -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 6.25 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn -
8 Royalty Pharma 28.45 Bn 27.61 Bn - 19.13 Bn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 1.30 Bn
10 Xencor 2.02 Bn 1.65 Bn - 608.12 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 608.12 Mn
Mar 31, 2026 624.17 Mn
Dec 31, 2025 755.34 Mn
Sep 30, 2025 758.45 Mn
Jun 30, 2025 765.37 Mn
Mar 31, 2025 794.25 Mn
Dec 31, 2024 837.63 Mn
Sep 30, 2024 878.72 Mn
Jun 30, 2024 728.47 Mn
Mar 31, 2024 784.83 Mn
Dec 31, 2023 851.57 Mn
Dec 31, 2022 727.50 Mn